K Number
K152054
Device Name
Confida Adaptive Sheath
Manufacturer
Date Cleared
2015-08-07

(15 days)

Product Code
Regulation Number
870.1340
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Confida™ Adaptive Sheath is intended to provide a conduit through the iliofemoral vessels for the insertion of diagnostic or interventional devices used during cardiovascular procedures, including transcatheter aortic valve replacement (TAVR).
Device Description
The Confida™ Adaptive Sheath is a single-use, disposable, hydrophilically coated sheath designed to provide a flexible and hemostatic conduit for the insertion of diagnostic and interventional devices, including devices used in transcatheter aortic valve replacement (TAVR). The Confida™ Adaptive Sheath is a prescription use device, intended to be used by professionals in healthcare/hospital facilities. There is only one model of the Confida™ Adaptive Sheath, corresponding to model number CAS131830. The Confida™ Adaptive Sheath is comprised of two components: ● Dilator component: The Dilator component includes a flexible, tapered distal tip that facilitates atraumatic tracking through the vasculature. The Dilator component contains an internal lumen able to accommodate up to a 0.035in (0.89mm) guidewire. ● Introducer Sheath component: A hydrophilic coating is applied to the sheath body to reduce the forces required for insertion into and withdrawal from the vasculature. The seal housing contains a hemostatic valve assembly designed to minimize blood loss during device use. The Introducer Sheath component contains a sideport extension with a three-way valve, providing a means for fluid to be flushed through the Introducer Sheath component during clinical use. The sheath body temporarily expands in diameter to allow the introduction and removal of devices up to 18 Fr in outer diameter, including devices used in TAVR procedures. There are no specific accessories required for use with the Confida™ Adaptive Sheath. The Confida™ Adaptive Sheath is designed for use with guidewires up to 0.035in (.89mm) in diameter, and has been developed for use with various devices used in diagnostic and interventional procedures, including TAVR procedures. The Confida™ Adaptive Sheath is classified as a surgically invasive device for short-term use (<24 hours) contacting circulatory blood, per ISO 10993-1:2009. The Confida™ Adaptive Sheath is sterilized by Ethylene Oxide (EtO) to a minimum sterility assurance level (SAL) of 10-6.
More Information

Not Found

No
The device description and performance studies focus on the physical properties and functionality of a medical sheath, with no mention of AI or ML technologies.

No.
The device is an introducer sheath intended to provide a conduit for other devices, not to provide therapeutic treatment itself.

No

The Confida™ Adaptive Sheath is designed to facilitate the insertion of diagnostic or interventional devices, not to perform diagnosis itself.

No

The device description clearly outlines physical components (dilator, introducer sheath, sideport extension, valve assembly) and mentions non-clinical testing related to material properties, mechanical performance, and biocompatibility, indicating it is a physical medical device, not software-only.

Based on the provided information, the Confida™ Adaptive Sheath is not an In Vitro Diagnostic (IVD) device.

Here's why:

  • Intended Use: The intended use is to provide a conduit for inserting diagnostic or interventional devices into the iliofemoral vessels during cardiovascular procedures. This involves direct interaction with the patient's circulatory system.
  • Device Description: The description details a physical sheath and dilator designed for insertion into the body. It focuses on features like flexibility, hemostasis, and facilitating the passage of other devices.
  • Mechanism of Action: The device's function is mechanical – creating a pathway within the body. It does not involve analyzing samples taken from the body (like blood, urine, or tissue) to provide diagnostic information.
  • Classification: The device is classified as a surgically invasive device for short-term use contacting circulatory blood, which aligns with a medical device used within the body, not an IVD.

In Vitro Diagnostic devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Confida™ Adaptive Sheath does not perform this function.

N/A

Intended Use / Indications for Use

The Confida™ Adaptive Sheath is intended to provide a conduit through the iliofemoral vessels for the insertion of diagnostic or interventional devices used during cardiovascular procedures, including transcatheter aortic valve replacement (TAVR).

Product codes

DYB

Device Description

The Confida™ Adaptive Sheath is a single-use, disposable, hydrophilically coated sheath designed to provide a flexible and hemostatic conduit for the insertion of diagnostic and interventional devices, including devices used in transcatheter aortic valve replacement (TAVR). The Confida™ Adaptive Sheath is a prescription use device, intended to be used by professionals in healthcare/hospital facilities. There is only one model of the Confida™ Adaptive Sheath, corresponding to model number CAS131830.

The Confida™ Adaptive Sheath is comprised of two components:

  • Dilator component: The Dilator component includes a flexible, tapered distal tip that facilitates atraumatic tracking through the vasculature. The Dilator component contains an internal lumen able to accommodate up to a 0.035in (0.89mm) guidewire.
  • Introducer Sheath component: A hydrophilic coating is applied to the sheath body to reduce the forces required for insertion into and withdrawal from the vasculature. The seal housing contains a hemostatic valve assembly designed to minimize blood loss during device use. The Introducer Sheath component contains a sideport extension with a three-way valve, providing a means for fluid to be flushed through the Introducer Sheath component during clinical use. The sheath body temporarily expands in diameter to allow the introduction and removal of devices up to 18 Fr in outer diameter, including devices used in TAVR procedures. There are no specific accessories required for use with the Confida™ Adaptive Sheath. The Confida™ Adaptive Sheath is designed for use with guidewires up to 0.035in (.89mm) in diameter, and has been developed for use with various devices used in diagnostic and interventional procedures, including TAVR procedures. The Confida™ Adaptive Sheath is classified as a surgically invasive device for short-term use (

§ 870.1340 Catheter introducer.

(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of a human figure, represented by three overlapping profiles, positioned to the right of the department's name. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the figure.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

August 7, 2015

Medtronic, Inc. c/o Mark Job Regulatory Technology Services LLC 1394 25th Street NW Buffalo, MN 55313

Re: K152054

Trade/Device Name: Confida Adaptive Sheath Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: II Product Code: DYB Dated: July 23, 2015 Received: July 23, 2015

Dear Mark Job:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

1

CFR Part 807); labeling (21 CFR Part 801; medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Bram D. Zuckerman -S

Bram Zuckerman, MD Director Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known)

Device Name Confida™ Adaptive Sheath

Indications for Use (Describe)

The Confida™ Adaptive Sheath is intended to provide a conduit through the iliofemoral vessels for the insertion of diagnostic or interventional devices used during cardiovascular procedures, including transcatheter aortic valve replacement (TAVR).

Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) Summary

..

As required by the Safe Medical Devices Act of 1990, coded under Section 513, part (1)(3)(A) of the Food, Drug and Cosmetic Act, a 510(k) summary upon which substantial equivalence determination is based is as follows:

Date Prepared:April 13, 2015
Applicant/
Submitter:Medtronic, Inc.
710 Medtronic Parkway
Minneapolis, MN 55432
USA
Phone: (763) 526-7890
Fax: (763) 526-7888
Contact Person:Matthew Lobeck
Regulatory Affairs Specialist
Medtronic Heart Valves
Phone: (763) 514-9515
Fax: (763) 514-9521
Email: matthew.lobeck@medtronic.com
Device Trade Name:Confida™ Adaptive Sheath
Model Number:CAS131830
Device Common
Name:Confida Sheath
Classification Name:Catheter Introducer
Classification:Class II, 21 CFR 870.1340
Product Code:DYB
Predicate Devices:Primary Predicate Device: Medtronic Sentrant Introducer Sheath with Hydrophilic Coating (K123990, cleared April 26, 2013) Secondary Predicate Device: Edwards eSheath Introducer Set (K141696, cleared September 18, 2014)
Device Description:The Confida™ Adaptive Sheath is a single-use, disposable, hydrophilically
coated sheath designed to provide a flexible and hemostatic conduit for the
insertion of diagnostic and interventional devices, including devices used in
transcatheter aortic valve replacement (TAVR). The Confida™ Adaptive
Sheath is a prescription use device, intended to be used by professionals in
healthcare/hospital facilities. There is only one model of the Confida™
Adaptive Sheath, corresponding to model number CAS131830.

4

The Confida™ Adaptive Sheath is comprised of two components:

● Dilator component: The Dilator component includes a flexible, tapered distal tip that facilitates atraumatic tracking through the vasculature. The Dilator component contains an internal lumen able to accommodate up to a 0.035in (0.89mm) guidewire. Introducer Sheath component: A hydrophilic coating is applied ● to the sheath body to reduce the forces required for insertion into and withdrawal from the vasculature. The seal housing contains a hemostatic valve assembly designed to minimize blood loss during device use. The Introducer Sheath component contains a sideport extension with a three-way valve, providing a means for fluid to be flushed through the Introducer Sheath component during clinical use. The sheath body temporarily expands in diameter to allow the introduction and removal of devices up to 18 Fr in outer diameter, including devices used in TAVR procedures. There are no specific accessories required for use with the Confida™ Adaptive Sheath. The Confida™ Adaptive Sheath is designed for use with guidewires up to 0.035in (.89mm) in diameter, and has been developed for use with various devices used in diagnostic and interventional procedures, including TAVR procedures. The Confida™ Adaptive Sheath is classified as a surgically invasive device for short-term use (